Patents Assigned to Foundation
-
Publication number: 20100278933Abstract: The invention relates to kinase inhibitor compounds and methods of identifying and using them. The invention further relates to pharmaceutical compositions and methods for treating disorders, especially cancer.Type: ApplicationFiled: June 5, 2008Publication date: November 4, 2010Applicant: University of Florida Research Foundation, IncInventors: Peter P. Sayeski, György M. Keserü
-
Publication number: 20100278864Abstract: An attenuated rabies virus for use as a live vaccine. The attenuated rabies virus expresses an immune factor that enhances immune response upon administration of the live vaccine.Type: ApplicationFiled: December 14, 2006Publication date: November 4, 2010Applicant: University of Georgia Research Foundation, Inc.Inventor: Zhen F. Fu
-
Publication number: 20100280513Abstract: A pulse delivery system for producing a spark in tissue is disclosed. The system can include at least two electrodes having sharp surface features, where the at least two electrodes are electrically isolated from one another. The sharp features of the electrodes can be separated by a distance of about 2 to 20 mm. The system can also include a pulse generator for delivering pulsed voltage differences between the at least two electrodes. The pulsed voltage differences can producing a voltage difference ranging from about 2.5 kV to about 35 kV for a duration of about 50 ns to 3 ?s. The system can include a controller for determining whether the plurality of pulsed voltage differences produced a spark between the at least two electrodes. A method of producing a spark in tissue for both therapeutic and cosmetic, i.e., non-therapeutic, applications is also disclosed.Type: ApplicationFiled: April 14, 2010Publication date: November 4, 2010Applicant: Old Dominion University Research FoundationInventors: Kolb F. Juergen, Scully Noah, Schoenbach H. Karl, Paithankar Dilip
-
Publication number: 20100278743Abstract: Methods for treating or preventing tauopathies and/or A? amyloidosis by modulating CRF receptor signaling. Accumulation of hyperphosphorlyated tau protein in the CNS may be reduced by administration of CRF-R1 selective antagonists and/or CRF-R2 selective agonists. For example, in some aspects, methods for preventing the onset of Alzheimer's disease by administration of CRF-R1 selective antagonist are provided.Type: ApplicationFiled: June 13, 2008Publication date: November 4, 2010Applicant: Research Development FoundationInventors: Robert A. Rissman, Kuo-Fen Lee, Wylie W. Vale, Paul E. Sawchenko
-
Publication number: 20100280358Abstract: In a single breath-hold the physiologic, morphologic and structural changes in multiple organs are detected and assessed. The main steps process include: polarizing the Xe-129 gas; inhalation or introduction of a certain pre-calculated amount of the gas and start of the breath-hold; acquisition of multiple spatially oriented spectrums, localized in the same plane (2D), in multiple different planes (3D) or in 3D plus at multiple time intervals (4D); stop the breath-hold; post-processing of the acquired data; evaluation of the multiple spectrums by comparison of the values in a region of interest with those in surrounding tissues or known as normal.Type: ApplicationFiled: April 30, 2010Publication date: November 4, 2010Applicant: University of Virginia Patent FoundationInventors: Jaime F. MATA, Kai Ruppert, John P. Mugler
-
Publication number: 20100280201Abstract: The invention provides polymers, methods of preparing polymers, and compositions that include polymers, wherein said polymers include a plurality of two-carbon repeating units in a polymer chain, wherein one or more of the two-carbon repeating units of the polymer chain have tertiary amine or pyridine-containing substituents; and at least about 10% of the nitrogen atoms of the tertiary amine or pyridine-containing substituents are quaternized with alkyl groups or with an alkyl group that contains one or more ethylene glycol groups. The alkyl or ethoxylated alkyl groups can also be at least partially fluorinated. The polymers can be used to provide antimicrobial surfaces and antifouling coatings.Type: ApplicationFiled: July 23, 2010Publication date: November 4, 2010Applicant: Cornell Research Foundation, Inc.Inventors: Christopher K. Ober, Sitaraman Krishnan, Qin Lin, Edward Kramer
-
Publication number: 20100279600Abstract: Disclosed is a method of using relay that may continuously transmit data without time division based on superposition coding in a communication system. When transmission of a relay-supported user signal via a base station-relay link is performed, the method of using relay based on the superposition coding reuses a resource allocated to a direct-transmission user based on the superposition coding to perform the transmission. According to example embodiments, a separate resource for the base station-relay link may not be needed, and continuous relay transmission is possible without time division, thereby substantially increasing frequency efficiency and reducing a transmission delay caused by the use of the relay.Type: ApplicationFiled: December 11, 2008Publication date: November 4, 2010Applicants: Electronics and Telecommunications Research Institute, Ajou University Industry-Academic Cooperation FoundationInventors: Taegyun Noh, Seong Keun Oh, Min Lee, Byung Jang Jeong, Hyun Kyu Chung
-
Publication number: 20100276661Abstract: Devices, methods, and techniques for frequency-dependent optical switching are provided. In one embodiment, a device includes a substrate, a first and a second optical-field confining structures located on the substrate, and a quantum structure disposed between the first and the second optical-field confining structures. The first optical-field confining structure may include a surface to receive photons. The second optical-field confining structure may be spaced apart from the first optical-field confining structure. The first and the second optical-field confining structures may be configured to substantially confine therebetween an optical field of the photons.Type: ApplicationFiled: April 30, 2009Publication date: November 4, 2010Applicant: University of Seoul Industry Cooperation FoundationInventor: Doyeol AHN
-
Publication number: 20100276730Abstract: Semiconductor devices having at least one barrier layer are disclosed. In some embodiments, a semiconductor device includes an active layer and one or more barrier layers disposed on either one side or both sides of the active layer. The active layer may be composed of a first compound semiconductor material, and the one or more barrier layers may be composed of a second compound semiconductor material. In some embodiments, the composition of the one or more barrier layers may be adjusted to increase an optical dipole matrix element.Type: ApplicationFiled: April 29, 2009Publication date: November 4, 2010Applicant: University of Seoul Industry Cooperation FoundationInventor: Doyeol AHN
-
Publication number: 20100276697Abstract: Semiconductor devices having strong excitonic binding are disclosed. In some embodiments, a semiconductor device includes at least one active layer composed of a first compound, and at least one barrier layer composed of a second compound and disposed on at least one surface of the at least one active layer. An energy band gap of the at least one barrier layer is wider than energy band gap of the at least one active layer, and the first and/or second compounds are selected to strengthen an excitonic binding between an electron and a hole in the at least one active layer.Type: ApplicationFiled: April 29, 2009Publication date: November 4, 2010Applicant: University of Seoul Industry Coorperation FoundationInventor: Doyeol AHN
-
Publication number: 20100279287Abstract: This invention relates generally to useful compositions and methods related to plant site-directed recombination. In particular, the invention relates to novel nucleic acid sequences unique to a portion of the sorghum NBS-LRR region, as well as vectors, seeds, plant parts and plants comprising these sequences. Methods to investigate recombination co-factors, and methods to investigate potential herbicides are within the scope. This invention also relates to fungal pathogens of sorghum, particularly Periconia circinata.Type: ApplicationFiled: February 25, 2008Publication date: November 4, 2010Applicant: University of Georgia Research Foundation, Inc.Inventors: Jeffrey L. Bennetzen, Ervin D. Nagy
-
Publication number: 20100279007Abstract: The disclosed method relates to manufacture of a near net-shaped products such as ceramic containing products such as ceramic-metal composites. The method entails forming a mixture of a build material and a binder and depositing that mixture onto a surface to produce a layer of the mixture. An activator fluid then is applied to at least one selected region of the layer to bond the binder to the build material to yield a shaped pattern. These steps may be repeated to produce a porous whitebody that is heat treated to yield a porous greenbody preform having a porosity of about 30% to about 70%. The greenbody then is impregnated with a molten material such as molten metal. Where the build material is SiC, the molten metal employed is Si to generate a SiC—Si composite.Type: ApplicationFiled: August 12, 2008Publication date: November 4, 2010Applicants: The Penn State Research Foundation, Storm Development, LLCInventors: Thomas D. Briselden, Thomas M. Reilly, David R. Forsman
-
Publication number: 20100276667Abstract: A nonvolatile memory electronic device including nanowire channel and nanoparticle-floating gate nodes, in which the nonvolatile memory electronic device, which comprises a semiconductor nanowire used as a charge transport channel and nanoparticles used as a charge trapping layer, is configured by allowing the nanoparticles to be adsorbed on a tunneling layer deposited on a surface of the semiconductor nanowire, whereby charge carriers moving through the nanowire are tunneled to the nanoparticles by a voltage applied to a gate, and then, the charge carriers are tunneled from the nanoparticles to the nanowire by the change of the voltage that has been applied to the gate, whereby the nonvolatile memory electronic device can be operated at a low voltage and increase the operation speed thereof.Type: ApplicationFiled: February 12, 2008Publication date: November 4, 2010Applicant: Korea University Industrial & Academic Collaboration FoundationInventors: Sangsig Kim, Chang Jun Yoon, Dong Young Jeong, Dong Hyuk Yeom
-
Publication number: 20100278401Abstract: An imaging and recordation system is provided. The system includes a high-power, focusing antenna for illuminating biological tissue. The system further includes a power source for powering the antenna. The system further includes a data acquisition module, for recording the dielectric properties of tissues illuminated by the high-power, focusing antenna. The system illuminates the tissues using ultrashort electrical pulses.Type: ApplicationFiled: December 19, 2008Publication date: November 4, 2010Applicant: Old Dominion University Research FoundationInventors: Karl H. Schoenbach, Shu Xiao
-
Publication number: 20100278870Abstract: The invention provides a method of inducing an immune response against malaria in a mammal. The method comprises intramuscularly administering to a mammal a composition comprising a pharmaceutically acceptable carrier and either or both of (a) a first adenoviral vector comprising a nucleic acid sequence encoding a P. falciparum circumsporozoite protein (CSP) operably linked to a human CMV promoter, and/or (b) a second adenoviral vector comprising a nucleic acid sequence encoding a P. falciparum apical membrane antigen 1 (AMA-1) antigen operably linked to a human CMV promoter.Type: ApplicationFiled: January 9, 2008Publication date: November 4, 2010Applicant: The Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc.Inventors: Joseph T. Bruder, C. Richter King, Thomas Richie, Keith Limbach, Denise Louise Doolan
-
Publication number: 20100280223Abstract: Techniques for determining an equilibrium structure of a protein in a predetermined environment, the protein having Ramachandran angles and a known denatured structure, are disclosed. In a preferred embodiment, a method is presented which involves determining a maximum RMS volume of the known denatured structure of the protein and calculating at least one force on the protein in its current structure in the predetermined environment. The net torque resulting from the at least one force for each of the Ramachandran angles of the protein is then determined. Then at least one section of the protein structure on a side of a Ramachandran angle with greatest torque is rotated to form a new structure. A new RMS volume for the new structure is then calculated, and the method is repeated using the new structure. The method ceases when the new RMS volume of the new protein structure is not less than the RMS volume of the starting structure.Type: ApplicationFiled: April 27, 2007Publication date: November 4, 2010Applicant: The Research Foundation of State University of New YorkInventors: Charles Michael Fortmann, Yeona Kang
-
Publication number: 20100275817Abstract: An asphalt binder includes asphalt and an asphalt binder modifier, which includes bio-oil. The asphalt binder can include a carboxyl additive. The asphalt can optionally include polymer-modified asphalt. An asphalt material includes mineral aggregate, an asphalt material binder including asphalt, and an asphalt binder modifier including bio-oil. A method for making the asphalt binder is disclosed. The asphalt material includes asphalt pavement and roofing shingles. The asphalt binder can be emulsified with water and a surfactant for use as a weatherproofing sealant or as an adhesive.Type: ApplicationFiled: May 3, 2010Publication date: November 4, 2010Applicant: Iowa State University Research Foundation, Inc.Inventors: Ronald Christopher WILLIAMS, Robert C. BROWN, Sheng TANG
-
Publication number: 20100278726Abstract: Modified antibodies, or antigen-binding fragments thereof, to the extracellular domain of human prostate specific membrane antigen (PSMA) are provided. The modified anti-PSMA antibodies, or antigen-binding fragments thereof, have been rendered less immunogenic compared to their unmodified counterparts to a given species, e.g., a human. Pharmaceutical compositions including the aforesaid antibodies, nucleic acids, recombinant expression vectors and host cells for making such antibodies and fragments are also disclosed. Methods of using the antibodies of the invention to detect human PSMA, or to ablate or kill a PSMA-expressing cell, e.g., a PSMA-expressing cancer or prostatic cell, either in vitro or in vivo, are also provided.Type: ApplicationFiled: January 25, 2010Publication date: November 4, 2010Applicant: Cornell Research Foundation, Inc.Inventor: Neil Bander
-
Publication number: 20100280365Abstract: A method provides guidance to the physician during a live bronchoscopy or other endoscopic procedures. The 3D motion of the bronchoscope is estimated using a fast coarse tracking step followed by a fine registration step. The tracking is based on finding a set of corresponding feature points across a plurality of consecutive bronchoscopic video frames, then estimating for the new pose of the bronchoscope. In the preferred embodiment the pose estimation is based on linearization of the rotation matrix. By giving a set of corresponding points across the current bronchoscopic video image, and the CT-based virtual image as an input, the same method can also be used for manual registration. The fine registration step is preferably a gradient-based Gauss-Newton method that maximizes the correlation between the bronchoscopic video image and the CT-based virtual image. The continuous guidance is provided by estimating the 3D motion of the bronchoscope in a loop.Type: ApplicationFiled: July 12, 2010Publication date: November 4, 2010Applicant: The Penn State Research FoundationInventors: William E. Higgins, Scott A. Merritt, Lav Rai
-
Patent number: 7824839Abstract: The invention provides various ionic and non-ionic photoacid generator compounds. Photoresist compositions that include the novel ionic and non-ionic photoacid generator compounds are also provided. The invention further provides methods of making and using the photoacid generator compounds and photoresist compositions disclosed herein. The compounds and compositions are useful as photoactive components in chemically amplified resist compositions for various microfabrication applications.Type: GrantFiled: October 21, 2008Date of Patent: November 2, 2010Assignee: Cornell Research Foundation, Inc.Inventors: Christopher K. Ober, Yi Yi, Ramakrishnan Ayothi